Announcement on the Holding Subsidiary's Obtaining of the "Drug GMP Certificate"
Release time:
2020-08-05
Securities Code: 600668 Securities Short Name: Jianfeng Group Announcement No.: Pro 2018-026
Bond Short Name: 13 Jianfeng 02 Bond Code: 122344
Announcement of Zhejiang Jianfeng Group Co., Ltd.
on the acquisition of the "Drug GMP Certificate" by the holding subsidiary
The board of directors and all directors of the company guarantee this announcement There are no false records, misleading statements or major omissions, and they are individually and jointly liable for the authenticity, accuracy and completeness of their contents.
Recently, Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "the company") holding subsidiary Zhejiang Jianfeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Pharmaceutical") received Zhejiang Food The "Drug GMP Certificate" issued by the Drug Administration. The relevant information is hereby announced as follows:
1. GMP Certification Related Information
Enterprise Name: Zhejiang Jianfeng Pharmaceutical Co., Ltd.
Address: No.
Certificate No.: No. 368 Jinqu Road, Jinhua Industrial Park, Zhejiang Province: ZJ20180081
Certification Scope: Eye Drops, Ear Drops
Valid: august 2, 2023
2. involves production line capacity and main products:
Production Line Name |
Design Annual Capacity |
Variety |
Eye Drops Production Line |
Million |
Sodium Hyaluronate Eye Drops |
Ear Drops Production Line |
.5 Million |
Ofloxacin Ear Drops |
Market Situation of Main Products of 3. Company
Drug Name |
Dosage Form |
functional indications |
main manufacturer |
sodium hyaluronate eye drops |
eye drops |
are used for Sjogren's syndrome, Sjogren's syndrome, xerophthalmia |
towering pharmaceutical (China) co., ltd ; Qilu Pharmaceutical Co., Ltd.; Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch; |
Ofloxacin Ear Drops |
Ear Drops |
is used to treat otitis media, otitis externa and tympanitis caused by sensitive bacteria |
Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd; Nanjing Tianlang Pharmaceutical Co., Ltd.; Wuhan Wujing Pharmaceutical Co., Ltd.; |
Note: 1. The information of "Main Manufacturers" in the fourth column of the table mainly comes from the website of china food and drug administration.
2, 2017, peak pharmaceutical sodium hyaluronate eye drops sales revenue of 15.9176 million yuan, the sales revenue of ofloxacin ear drops was 1.2665 million yuan.
Impact of 4. on Listed Companies and Risk Tips
The "Drug GMP Certificate" obtained by Jianfeng Pharmaceutical this time is not the certification certificate of the new production line, but the certificate obtained after the GMP certificate of its original eye drop and ear drop production line expires and is re-certified. Obtaining the GMP certificate again will help ensure the product quality and production capacity of Jianfeng Pharmaceutical, ensure market supply, and will not have a significant impact on the company's current operations. The specific future sales of various drugs of
Company may be affected by market environment, industry policy, supply and demand relationship and other factors, with uncertainty. Please the majority of investors cautious decision-making, pay attention to prevent investment risk.
is hereby announced.
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
August 14, 2018
More information
Peak re-listed China's top 100 cement production capacity Daye peak won the "smart factory leader"
On July 11-12, the 2022 China Cement Industry Summit and TOP100 Award Ceremony organized by China Cement Network, an authoritative media of China's cement industry, was held in Hangzhou. Jianfeng Group once again ranked among the top 100 cement clinker production capacity in China.
2022
08-04
On the afternoon of July 12, the party Committee of the group company held a special meeting attended by party Committee members, senior and middle-level management backbones, heads of grass-roots party organizations and all party members of the group headquarters to learn and convey the spirit of the 15th party congress of the communist party of China in Zhejiang province.
2022
07-24
On the morning of July 1, more than 40 members of the group's party committee, party members of various branches of the group headquarters, and party members of subordinate enterprise branches went to the Shuanglong Hydropower Station, the Red Education Base of Jinhua City, to receive party spirit and revolutionary tradition education.
2022
07-14
Vocational skill level identification examination!
On June 16 and 18, the theoretical and practical examinations for the determination of professional skill level in the peak pharmaceutical sector were held successively in Jinxi pharmaceutical factory. The independent identification of vocational skill level includes three occupations (types of work): pharmaceutical preparation worker, chemical inspector and organic synthesis worker, basically covering the main posts in the pharmaceutical sector, with a total of 125 employees signing up for the identification.
2022
06-21
On June 16, the Jianfeng Pharmaceutical Quality Research and Development Party Branch and the Jinhua Vocational Skills Management Service Center Party Branch held a signing ceremony in Jinxi Factory to establish a party building alliance.
2022
06-21
Jinhua Mayor Xing Zhihong to Peak Research
On the afternoon of June 1, Jinhua Mayor Xing Zhihong, Wucheng District Party Committee Secretary Gao Feng, District Mayor Hu Yuxian, and heads of the Municipal Economic and Information Bureau, Development and Reform Bureau and other departments went to the group headquarters to discuss and exchange with the leaders of the group company to understand the development of the enterprise. Solicit opinions and suggestions from enterprises on government work. After understanding the current business situation of the peak, Xing Zhihong pointed out that focus, follow the right path, frontier, steady, is the peak to long-term prosperity of the magic weapon, must continue to adhere.
2022
06-13